UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Differential Immune Response Patterns Induced by Anionic and Cationic Lipid Adjuvants in Intranasal Anti-Influenza Immunization

Vaccines (Basel), 2024-03, Vol.12 (3), p.320

2024

Volltextzugriff (PDF)

Human IgM monoclonal antibodies block HIV-transmission to immune cells in cervico-vaginal tissues and across polarized epithelial cells in vitro

Scientific reports, 2018-07, Vol.8 (1), p.10180-12, Article 10180

2018

Volltextzugriff (PDF)

Long-Lasting Mucosal and Systemic Immunity against Influenza A Virus Is Significantly Prolonged and Protective by Nasal Whole Influenza Immunization with Mucosal Adjuvant N3 and DNA-Plasmid Expressing Flagellin in Aging In- and Outbred Mice

Vaccines (Basel), 2019-07, Vol.7 (3), p.64

2019

Volltextzugriff (PDF)

Intranasal Coronavirus SARS-CoV-2 Immunization with Lipid Adjuvants Provides Systemic and Mucosal Immune Response against SARS-CoV-2 S1 Spike and Nucleocapsid Protein

Vaccines (Basel), 2022-03, Vol.10 (4), p.504

2022

Volltextzugriff (PDF)

Mucosal and Plasma IgA from HIV-1-Exposed Uninfected Individuals Inhibit HIV-1 Transcytosis Across Human Epithelial Cells

The Journal of immunology (1950), 2000-11, Vol.165 (9), p.5170-5176

2000

Volltextzugriff (PDF)

Mucosal and plasma IgA from HIV-exposed seronegative individuals neutralize a primary HIV-1 isolate

AIDS (London), 2000-09, Vol.14 (13), p.1917-1920

2000

Volltextzugriff (PDF)

Intranasal HIV-1-gp160-DNA/gp41 Peptide Prime-Boost Immunization Regimen in Mice Results in Long-Term HIV-1 Neutralizing Humoral Mucosal and Systemic Immunity

The Journal of immunology (1950), 2004-12, Vol.173 (11), p.7078-7089

2004

Volltextzugriff (PDF)

DNA-Encoded Flagellin Activates Toll-Like Receptor 5 (TLR5), Nod-like Receptor Family CARD Domain-Containing Protein 4 (NRLC4), and Acts as an Epidermal, Systemic, and Mucosal-Adjuvant

Vaccines (Basel), 2013-09, Vol.1 (4), p.415-443

2013

Volltextzugriff (PDF)

Serum IgA of HIV-exposed uninfected individuals inhibit HIV through recognition of a region within the alpha-helix of gp41

AIDS (London), 2002-09, Vol.16 (13), p.1731-1741

2002

Volltextzugriff (PDF)

Cross-clade HIV-1-specific neutralizing IgA in mucosal and systemic compartments of HIV-1-exposed, persistently seronegative subjects

Journal of acquired immune deficiency syndromes (1999), 2002-08, Vol.30 (4), p.413-420

2002

Volltextzugriff (PDF)

A novel DNA adjuvant, N3, enhances mucosal and systemic immune responses induced by HIV-1 DNA and peptide immunizations

Vaccine, 2006-05, Vol.24 (21), p.4494-4497

2006

Volltextzugriff (PDF)

Functional HIV-1 specific IgA antibodies in HIV-1 exposed, persistently IgG seronegative female sex workers

IMMUNOLOGY LETTERS, 2001-11, Vol.79 (1), p.29-36

2001

Volltextzugriff (PDF)

Short Communication: Antiretroviral Therapy Does Not Induce HIV Type 1-Specific Neutralizing Activity against Autologous HIV Type 1 Isolates

AIDS research and human retroviruses, 2006-09, Vol.22 (9), p.908-911

2006

Volltextzugriff (PDF)

Antiretroviral therapy does not induce HIV type 1-specific neutralizing activity against autologous HIV type 1 isolates

AIDS research and human retroviruses, 2006-09, Vol.22 (9), p.908

2006

Volltextzugriff (PDF)

A novel DNA adjuvant, N3, enhances mucosal and systemic immune responses induced by HIV-1 DNA and peptide immunizations: DNA Vaccines

Vaccine, 2006, Vol.24 (21), p.4494-4497

2006

Volltextzugriff (PDF)

Mapping of B-cell epitopes in rabbits immunised with various gag antigens for the production of HIV-1 gag capture ELISA reagents

Journal of immunological methods, 2000-04, Vol.238 (1), p.69-80

2000

Volltextzugriff (PDF)

Human Immunodeficiency Virus Type 1 Nef Epitopes Recognized in HLA-A2 Transgenic Mice in Response to DNA and Peptide Immunization

Virology (New York, N.Y.), 2000-07, Vol.273 (1), p.112-119

2000

Volltextzugriff (PDF)

Seroreactivity to HIV-1 V3 subtypes A to H peptides of Argentinian HIV-positive sera

Journal of acquired immune deficiency syndromes and human retrovirology, 1998-02, Vol.17 (2), p.156-159

1998

Volltextzugriff (PDF)

HTLV-I/II survey on hemodialysis patients in Buenos Aires

Journal of acquired immune deficiency syndromes and human retrovirology, 1996-08, Vol.12 (5), p.525

1996

Volltextzugriff (PDF)

IGF1-mediated human embryonic stem cell self-renewal recapitulates the embryonic niche

Nature communications, 2020-02, Vol.11 (1), p.764-764, Article 764

2020

Volltextzugriff (PDF)

Three vs twelve months of dual antiplatelet therapy after zotarolimus-eluting stents: the OPTIMIZE randomized trial

JAMA : the journal of the American Medical Association, 2013-12, Vol.310 (23), p.2510

2013

Volltextzugriff (PDF)

EVALUATION OF NUCLEAR FACTOR-ΚB, ITS LIGAND, AND OSTEOPROTEGERIN EXPRESSION IN THE NEIGHBOR BONE OF ORAL SQUAMOUS CELL CARCINOMA LESION

Oral surgery, oral medicine, oral pathology and oral radiology, 2020-01, Vol.129 (1), p.e138

2020

Volltextzugriff (PDF)

Pediatric Soft Tissue Tumors With BCOR ITD Express EGFR but Not OLIG2

Pediatric and developmental pathology, 2020-12, Vol.23 (6), p.424-430

2020

Volltextzugriff (PDF)

Mixtures research at NIEHS: An evolving program

Toxicology (Amsterdam), 2013-11, Vol.313 (2-3), p.94-102

2013

Volltextzugriff (PDF)

EVALUATION OF NUCLEAR FACTOR-ΚB, ITS LIGAND, AND OSTEOPROTEGERIN EXPRESSION IN THE NEIGHBOR BONE OF ORAL SQUAMOUS CELL CARCINOMA LESION

Oral surgery, oral medicine, oral pathology and oral radiology, 2020-01, Vol.129 (1), p.e138-e138

2020

Volltextzugriff (PDF)

1 – 25 von 32

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(28)
Mit Volltextzugriff
(25)

Publikationsform

Artikel
(32)

Sprache

Englisch
(32)

Erscheinungsjahr

n.n

Thema

Science & Technology
(25)
Life Sciences & Biomedicine
(23)
Humans
(16)
Medicin Och Hälsovetenskap
(15)
Immunology
(14)
Female
(12)
Hiv-1 - Immunology
(10)
Animals
(9)
Biological And Medical Sciences
(9)
Aids/hiv
(8)
Human Immunodeficiency Virus 1
(8)
Infectious Diseases
(7)
Male
(6)
Neutralization Tests
(6)
Virology
(6)
Fundamental And Applied Biological Sciences. Psychology
(5)
Hiv Seronegativity - Immunology
(5)
Immunity, Mucosal
(5)
Immunization
(5)
Medical Sciences
(5)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Differential Immune Response Patterns Induced by Anionic and Cationic Lipid Adjuvants in Intranasal Anti-Influenza Immunization

Human IgM monoclonal antibodies block HIV-transmission to immune cells in cervico-vaginal tissues and across polarized epithelial cells in vitro

Long-Lasting Mucosal and Systemic Immunity against Influenza A Virus Is Significantly Prolonged and Protective by Nasal Whole Influenza Immunization with Mucosal Adjuvant N3 and DNA-Plasmid Expressing Flagellin in Aging In- and Outbred Mice

Intranasal Coronavirus SARS-CoV-2 Immunization with Lipid Adjuvants Provides Systemic and Mucosal Immune Response against SARS-CoV-2 S1 Spike and Nucleocapsid Protein

Mucosal and Plasma IgA from HIV-1-Exposed Uninfected Individuals Inhibit HIV-1 Transcytosis Across Human Epithelial Cells

Mucosal and plasma IgA from HIV-exposed seronegative individuals neutralize a primary HIV-1 isolate

Intranasal HIV-1-gp160-DNA/gp41 Peptide Prime-Boost Immunization Regimen in Mice Results in Long-Term HIV-1 Neutralizing Humoral Mucosal and Systemic Immunity

DNA-Encoded Flagellin Activates Toll-Like Receptor 5 (TLR5), Nod-like Receptor Family CARD Domain-Containing Protein 4 (NRLC4), and Acts as an Epidermal, Systemic, and Mucosal-Adjuvant

Serum IgA of HIV-exposed uninfected individuals inhibit HIV through recognition of a region within the alpha-helix of gp41

Cross-clade HIV-1-specific neutralizing IgA in mucosal and systemic compartments of HIV-1-exposed, persistently seronegative subjects

A novel DNA adjuvant, N3, enhances mucosal and systemic immune responses induced by HIV-1 DNA and peptide immunizations

Functional HIV-1 specific IgA antibodies in HIV-1 exposed, persistently IgG seronegative female sex workers

Short Communication: Antiretroviral Therapy Does Not Induce HIV Type 1-Specific Neutralizing Activity against Autologous HIV Type 1 Isolates

Antiretroviral therapy does not induce HIV type 1-specific neutralizing activity against autologous HIV type 1 isolates

A novel DNA adjuvant, N3, enhances mucosal and systemic immune responses induced by HIV-1 DNA and peptide immunizations: DNA Vaccines

Mapping of B-cell epitopes in rabbits immunised with various gag antigens for the production of HIV-1 gag capture ELISA reagents

Human Immunodeficiency Virus Type 1 Nef Epitopes Recognized in HLA-A2 Transgenic Mice in Response to DNA and Peptide Immunization

Seroreactivity to HIV-1 V3 subtypes A to H peptides of Argentinian HIV-positive sera

HTLV-I/II survey on hemodialysis patients in Buenos Aires

IGF1-mediated human embryonic stem cell self-renewal recapitulates the embryonic niche

Three vs twelve months of dual antiplatelet therapy after zotarolimus-eluting stents: the OPTIMIZE randomized trial

EVALUATION OF NUCLEAR FACTOR-ΚB, ITS LIGAND, AND OSTEOPROTEGERIN EXPRESSION IN THE NEIGHBOR BONE OF ORAL SQUAMOUS CELL CARCINOMA LESION

Pediatric Soft Tissue Tumors With BCOR ITD Express EGFR but Not OLIG2

Mixtures research at NIEHS: An evolving program

EVALUATION OF NUCLEAR FACTOR-ΚB, ITS LIGAND, AND OSTEOPROTEGERIN EXPRESSION IN THE NEIGHBOR BONE OF ORAL SQUAMOUS CELL CARCINOMA LESION

Suchergebnisse filtern